NCT06485934 Kinesiophobia Scale for the Upper Extremity
| NCT ID | NCT06485934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emre Şenocak |
| Condition | Shoulder Injuries |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-07-22 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-07-22 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Questionnaires/scales used to evaluate kinesiophobia in the literature are limited and are not specific to the upper extremity in existing scales. For this reason, the primary purpose and subject of the study is to develop a multi-factor kinesiophobia scale specific to shoulder problems. The study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.
Eligibility Criteria
Inclusion Criteria: * Tampa Kinesiophobia Score \>37 points * Presence of traumatological, orthopedic and rheumatological pathology in the upper extremity * Mini-Mental State Examination score \>24 points Exclusion Criteria: * Malignancy, * Psychiatric drug use, * Use of painkillers during evaluation periods, * Those who received physiotherapy before the study (last 6 months), * Those whose education level is below secondary school level,
Contact & Investigator
Abdurrahman Tanhan, PhD
STUDY CHAIR
Bitlis Eren University
Frequently Asked Questions
Who can join the NCT06485934 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Shoulder Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06485934 currently recruiting?
Yes, NCT06485934 is actively recruiting participants. Contact the research team at emre.senocak@windowslive.com for enrollment information.
Where is the NCT06485934 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06485934 clinical trial?
NCT06485934 is sponsored by Emre Şenocak. The principal investigator is Abdurrahman Tanhan, PhD at Bitlis Eren University. The trial plans to enroll 150 participants.